Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 20Lymphoma, Follicular 19Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, B-Cell 11Neoplasms 10Recurrence 8Lymphoma, Mantle-Cell 7Lymphoma, T-Cell, Peripheral 6Leukemia 5Hematologic Diseases 5Sarcoma, Kaposi 3Neuroblastoma 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3HIV Infections 3Acquired Immunodeficiency Syndrome 3Wilms Tumor 2Small Cell Lung Carcinoma 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphatic Diseases 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Burkitt Lymphoma 2Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1

Interventions

Vincristine 1Rituximab 1Prednisone 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Acromesomelic dysplasia, Maroteaux type × Vincristine × Clear all
NCT00931918 2017-01-11

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

Takeda

Phase 2 Completed
206 enrolled 18 charts
Lymphoid

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡